Abstract: The present invention relates to pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds, and methods of preparation of these compounds. The present invention also relates to pharmaceutical compositions comprising pyrroloquinolinyl-pyrrole-2,5-dione compounds and pyrroloquinolinyl-pyrrolidine-2,5-dione compounds. The present invention provides methods of treating a cell proliferative disorder, such as a cancer, by administering to a subject in need thereof a therapeutically effective amount of a pyrroloquinolinyl-pyrrole-2,5-dione compound or pyrroloquinolinyl-pyrrolidine-2,5-dione compound of the present invention.

Abstract: A container has openings at each end and has two compartments for holding two complementary materials. The container stands on either end and can dispense one of the two materials from each end. In one embodiment the container is separable into two individual containers. The individual containers are attached together using various means such as shrink wrap material, perforated strips, interlocking sections and the like.

Abstract: The invention is the method of using the soluble modified receptor erbB3 to treat breast cancer by competitively inhibiting ligands, such as heregulin, from binding to erbB3 tyrosine kinase receptors on cell surfaces.

Abstract: A method and apparatus for forming a covered endoprosthesis employs a conformed polymeric coating about an expandable stent. The expandable stent has an open tubular construction. A first polymeric liner is positioned about an inner surface of the tubular stent and a second polymeric liner is positioned about an outer surface of the tubular stent. The first and second polymeric liners are conformed to the tubular stent and laminated together through the open construction of the stent at a location coextensive with the inner surface of the tubular stent.

Abstract: Provided herein are mixtures of C4 grasses and legumes, and methods of using such mixtures to sequester carbon. Methods of using the sequestered carbon in the form of, for example, carbon credits, to offset or mitigate carbon usage also are provided.

Abstract: A method to wirelessly network a sensor/actuator node is described. The sensor/actuator node is installed in a sensor/actuator node network and arranged in a hierarchical manner with a plurality of node levels and a cluster head network. A unique node identifier is assigned to the sensor node and the sensor node network is initialized. The sensor node is woken-up to perform a task and then set to an active low power mode.

Abstract: A method to wirelessly network a sensor/actuator node is described. The sensor/actuator node is installed in a sensor/actuator node network and arranged in a hierarchical manner with a plurality of node levels and a cluster head network. A unique node identifier is assigned to the sensor node and the sensor node network is initialized. The sensor node is woken-up to perform a task and then set to an active low power mode.

Abstract: The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.

Abstract: The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.

Abstract: The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.

Abstract: The present invention relates to novel lipopeptide compounds. The invention also relates to pharmaceutical compositions of these compounds and methods of using these compounds as antibacterial compounds. The invention also relates to methods of producing these novel lipopeptide compounds and intermediates used in producing these compounds.

Abstract: An orthodontic flossing implement and method of use thereof, wherein the present implement comprises a handle from which extends a flat, narrow arm, and wherein the tip of the arm comprises a slit or aperture through which a desired length of floss is inserted. The narrow arm, with the length of floss threaded therethrough, may be quickly and simply inserted underneath a selected arch or pass of a brace wire, wherein the length of floss hanging from the arm aperture may then be easily grasped and worked within and along the inter-dental space disposed proximate or behind the selected wire arch. Thereafter, the arm of the flossing implement is retracted and systematically moved between each arch of the wire, whilst maintaining the floss through the aperture of the arm, whereupon each respective underlying inter-dental space may be conveniently and quickly flossed.

Abstract: In general, the present invention relates to compounds capable of inhibiting P38, methods for inhibiting P38 in vivo or in vitro, diagnostics for determining activity in the treatment of P38 and/or cytokine-associated conditions and methods for treating conditions associated with P38 activity or cytokine activity.

Abstract: A venous valve-with a structural member and valve leaflets that provide a sinus.

Abstract: Pagination of a document is achieved through the use of an index of predetermined hard breaks within the document. When a selected portion of the document is identified, an immediately prior hard break relative to the selected portion is identified. Active formatting tags applicable to content following the identified hard break are identified to determine proper layout for any intervening pages between the identified hard break and the selected portion. In this manner, a complete and reproducible page can be associated with the selected portion, independent of page number determination. To determine a page number, page counts between hard breaks are stored. A sum of page counts between hard breaks is calculated up to the identified hard break. The final page number is this sum plus the number of pages determined between the identified hard break and the reproducible page.

Abstract: A venous valve with a frame and valve leaflets that provide a sinus pocket. The venous valve provides for unidirectional flow of a liquid through the valve.